{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:30:54Z","timestamp":1789245054284,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":890,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Cancer Institute, National Heart, Lung and Blood Institute, and National Institute of Allergy and Infectious Diseases","award":["U24-CA76518"],"award-info":[{"award-number":["U24-CA76518"]}]},{"name":"National Cancer Institute and National Heart, Lung and Blood Institute","award":["5U01HL069294"],"award-info":[{"award-number":["5U01HL069294"]}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"crossref","award":["HHSH234200637015C"],"award-info":[{"award-number":["HHSH234200637015C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"crossref","award":["N00014-06-1-0704"],"award-info":[{"award-number":["N00014-06-1-0704"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"crossref","award":["N00014-08-1-0058"],"award-info":[{"award-number":["N00014-08-1-0058"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AABB, Allos"},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"crossref","award":["HHSH234200637018C"],"award-info":[{"award-number":["HHSH234200637018C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.bbmt.2012.04.001","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T00:07:19Z","timestamp":1333498039000},"page":"1620-1628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Costs and Cost-Effectiveness of Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"18","author":[{"given":"Jaime M.","family":"Preussler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Denzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet S.","family":"Majhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2012.04.001_bib1","first-page":"87","article-title":"2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders","author":"Pasquini","year":"2010","journal-title":"Clin Transpl"},{"key":"10.1016\/j.bbmt.2012.04.001_bib2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2012.04.001_bib3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbmt.2011.03.008","article-title":"Allogeneic transplant physician and center capacity in the United States","volume":"17","author":"Majhail","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib4","unstructured":"Stranges E, Russo A, Friedman B. Procedures with the most rapidly increasing hospital costs, 2004\u20132007. Healthcare Cost and Utilization Project (HCUP) statistical brief 82. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK53597\/. Accessed January 9,\u00a02012."},{"key":"10.1016\/j.bbmt.2012.04.001_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/jnci\/djp472","article-title":"When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology","volume":"102","author":"Greenberg","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bbmt.2012.04.001_bib6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbmt.2010.03.016","article-title":"The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia","volume":"16","author":"Lin","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib7","unstructured":"National Information Center on Health Services Research and Health Care Technology. HTA 101: IV. Cost analysis methods. Available from: http:\/\/www.nlm.nih.gov\/nichsr\/hta101\/ta10106.html. Accessed October 5,\u00a02011."},{"key":"10.1016\/j.bbmt.2012.04.001_bib8","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1001\/jama.1989.03430200123038","article-title":"Clinical economics: a guide to the economic analysis of clinical practices","volume":"262","author":"Eisenberg","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2012.04.001_bib9","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","first-page":"434","article-title":"Outcomes research in hematopoietic cell transplantation","author":"Lee","year":"2004"},{"key":"10.1016\/j.bbmt.2012.04.001_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0749-0704(05)70015-4","article-title":"Evidence-based medicine and cost-effectiveness analysis","volume":"14","author":"Chalfin","year":"1998","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.bbmt.2012.04.001_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/annonc\/mdl420","article-title":"Cost-effectiveness of postremission intensive therapy in patients with acute leukemia","volume":"18","author":"Yu","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2012.04.001_bib12","first-page":"1565","article-title":"Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome","volume":"18","author":"Imataki","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bbmt.2012.04.001_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bmt.1701160","article-title":"Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?","volume":"21","author":"Waters","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib14","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.bbmt.2012.04.001_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7326\/0003-4819-113-2-147","article-title":"A clinician\u2019s guide to cost-effectiveness analysis","volume":"113","author":"Detsky","year":"1990","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.bbmt.2012.04.001_bib16","series-title":"Designing and Conducting Cost-Effectiveness Analyses in Medicine and Health Care","author":"Muennig","year":"2002"},{"key":"10.1016\/j.bbmt.2012.04.001_bib17","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.bbmt.2012.04.001_bib18","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1200\/JCO.1999.17.9.2811","article-title":"Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?","volume":"17","author":"Rizzo","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.04.001_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbmt.2009.01.011","article-title":"Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bmt.1705733","article-title":"Lower costs associated with hematopoietic cell transplantation using reduced-intensity vs high-dose regimens for hematological malignancy","volume":"40","author":"Saito","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbmt.2007.10.010","article-title":"Costs of allogeneic hematopoietic cell transplantation with high-dose regimens","volume":"14","author":"Saito","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.2000.18.1.64","article-title":"Predicting costs of stem cell transplantation","volume":"18","author":"Lee","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.04.001_bib23","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/cncr.23281","article-title":"In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies","volume":"112","author":"Jones","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2012.04.001_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.tp.0000226171.43943.d3","article-title":"Costs of allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Svahn","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.04.001_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bmt.1705109","article-title":"Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia","volume":"36","author":"Cordonnier","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib26","first-page":"2565","article-title":"Cost analysis of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia at King Chulalongkorn Memorial Hospital","volume":"90","author":"Ngamkiatphaisan","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.bbmt.2012.04.001_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ctrv.2003.11.002","article-title":"Economic burden of acute myeloid leukemia: a literature review","volume":"30","author":"Redaelli","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bbmt.2012.04.001_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/pbc.22250","article-title":"Costs of pediatric allogeneic hematopoietic cell transplantation","volume":"54","author":"Majhail","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2012.04.001_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00019053-200927010-00006","article-title":"Cost-effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin\u2019s lymphoma","volume":"27","author":"Fagnoni","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bbmt.2012.04.001_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1524-4733.2007.00180.x","article-title":"The cost-effectiveness of stem cell transplantations from unrelated donors in adult patients with acute leukemia","volume":"10","author":"Costa","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.bbmt.2012.04.001_bib31","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.bmt.1703310","article-title":"A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1-year follow-up procedures","volume":"28","author":"Mishra","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib32","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1097\/01.TP.0000129409.84087.62","article-title":"Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective multicenter French study","volume":"77","author":"Esp\u00e9rou","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.04.001_bib33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/bmt.2011.126","article-title":"Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs","volume":"47","author":"Faucher","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib34","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0959-8049(01)00198-8","volume":"37","author":"van Agthoven","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2012.04.001_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1703641","article-title":"Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia","volume":"30","author":"van Agthoven","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.001_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/10428190309178811","article-title":"Cost-effectiveness of a transplantation strategy compared to melphalan and prednisone in younger patients with multiple myeloma","volume":"44","author":"Kouroukis","year":"2003","journal-title":"Leuk Lymphoma"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:42:02Z","timestamp":1761057722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879112001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1083879112001395"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.04.001","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Costs and Cost-Effectiveness of Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}